Background
==========

*Pasteurella multocida*is a gram--negative bacterial pathogen that has a unique history of serving as a model species for new discoveries. In his seminal experiments in the late eighteenth century, Louis Pasteur demonstrated both attenuation as well as protective immune response utilizing *P. multocida*in birds \[[@B1],[@B2]\]. *P. multocida*is also an excellent model species for studying the effects of antibiotics on gram-negative bacteria because its short lipopolysaccharide O side chains make it more permeable, allowing investigations on the effects of antibiotics on bacterial metabolism \[[@B3]\].

Of the different *P. multocida*subspecies, multocida has a broad host range and causes diseases in poultry, cattle, pigs, and rabbits \[[@B4]\]. Zoonosis with *P. multocida*is caused by cat and dog bites and scratches and respiratory infection \[[@B5]\]. Fowl cholera (avian pasteurellosis) caused by *P. multocida*can be either chronic or acute and is a septicemic disease that causes significant economic loss to the poultry industry. Due to the importance of this pathogen to the avian community, the genome of an isolate recovered from chicken fowl cholera (strain Pm70) was sequenced in 2001 \[[@B6]\]. The genome sequence has enabled subsequent functional genomics research with this species \[[@B7]-[@B9]\]. It has also enabled investigations on the proteomic and transcriptomic response of *P. multocida*Pm70 to sub-MICs of antibiotics \[[@B10]-[@B12]\].

Much attention has been focused on characterization of specific antibiotic resistance mechanisms; however, recent studies are shedding light on non-target effects of antibiotics. In the current study, we used *P. multocida*as a model species to investigate the effects of three antibiotics with disparate mechanisms of action (amoxicillin, chlortetracycline, and enrofloxacin) on bacterial metabolism. Because biological systems utilize highly complex, interrelated metabolic and signaling networks, a thorough understanding of bacterial physiology requires studying the global response to a given stimulus in the context of interacting gene networks. Computational systems biology facilitates this level of analysis. Systems level analysis can identify key regulatory elements of a molecular interaction network; dynamic changes in these elements govern a response \[[@B13]\].

Application of systems approaches to *P. multocida*is still in the initial stages, but we have started using these methods to characterize the *P. multocida*response to antibiotics at the proteome level \[[@B11]\]. Here we describe the use of systems analysis at the transcriptome level to investigate the *P. multocida*response to sub-MICs of antibiotics.

Results and discussion
======================

Differentially expressed genes
------------------------------

Statistical analysis of microarray data revealed that 1/4 MIC of AMX, CTC, and ENR resulted in significant changes in expression of approximately 25% of the genome (525 genes, Additional file [1](#S1){ref-type="supplementary-material"}, supplemental table 1). The differences in gene expression that were determined to be statistically significant ranged from as small as a 5% decrease (relative to control) to as high as an 11.5-fold increase in expression (*recN*, Table [1](#T1){ref-type="table"}). Earlier microarray studies with *P. multocida*arbitrarily chose a 1.5-fold significant change in gene expression as differentially regulated genes. Instead of choosing a pre-determined threshold for determining the biological relevance of changes in gene expression, we considered every significant change in expression to be a valid change based on our rigorous statistical testing. We validated changes as small as a 15% decrease or increase (for example, expression of *murA*in response to AMX and ENR, respectively) (Additional file [1](#S1){ref-type="supplementary-material"}, supplemental table 1) by qPCR. Figure [1](#F1){ref-type="fig"} shows the correlation between the trends observed in microarray and qPCR for the subset of genes with qPCR validations.

###### 

Differential expression of *P. multocida*genes involved in SOS response

  GeneID    Product Name                                   Locus   AMX\*   CTC\*   ENR\*
  --------- ---------------------------------------------- ------- ------- ------- -------
  1244239   ImpA                                           impA    -0.52   -0.53   4.55
  1244433   DNA-binding protein Fis                        fis     ns      ns      1.41
  1244528   LexA repressor                                 lexA    ns      1.60    9.87
  1244611   Hypothetical protein PM1264                    \-      -0.78   -0.57   ns
  1244637   Transcriptional repressor protein MetJ         metJ    -0.53   -0.74   -0.80
  1244659   Hypothetical protein PM1312                    \-      -0.56   -0.68   -0.31
  1244737   DNA-directed RNA polymerase subunit alpha      rpoA    ns      -0.77   1.27
  1244795   Hypothetical protein PM1448                    \-      -0.81   -0.70   1.29
  1244828   Hypothetical protein PM1481                    \-      -0.53   -0.51   -0.51
  1244993   Hypothetical protein PM1646                    \-      -0.62   ns      -0.70
  1245061   Hypothetical protein PM1714                    \-      -0.74   -0.91   ns
  1245083   DNA-directed RNA polymerase subunit beta\'     rpoC    ns      -0.76   -0.87
  1245184   ATP-dependent helicase HepA                    hepA    -0.77   -0.77   1.69
  1245314   DNA-binding transcriptional activator GutM     gutM    -0.55   -0.69   -0.62
  1243539   Hypothetical protein PM0192                    recJ    -0.77   -0.79   1.24
  1243679   Hypothetical protein PM0332                    recN    ns      ns      11.54
  1243758   DNA-dependent helicase II                      uvrD    ns      ns      4.26
  1243814   DNA polymerase IV                              dinP    -0.76   -0.83   1.83
  1244020   Hypothetical protein PM0673                    \-      -0.63   -0.81   -0.47
  1244323   Holliday junction DNA helicase B               ruvB    ns      -0.78   2.37
  1244324   Holliday junction DNA helicase motor protein   ruvA    ns      ns      3.39
  1244459   DeaD                                           deaD    -0.78   -0.72   -0.67
  1244499   DNA repair protein RadC                        radC    -0.52   -0.60   -0.65
  1244507   DNA polymerase III subunit beta                dnaN    ns      ns      1.41
  1244526   Primosomal replication protein N               priB    ns      ns      1.67
  1244563   DNA polymerase III subunit delta               holA    ns      -0.88   1.38
  1244666   MutY                                           mutY    -0.68   -0.86   1.17
  1244774   RecQ                                           recQ    -0.86   -0.84   1.11
  1244823   DNA gyrase subunit B                           gyrB    ns      1.36    1.45
  1245063   NAD-dependent DNA ligase LigA                  ligA    -0.84   1.08    1.56
  1245164   Recombinase A                                  recA    ns      ns      9.96
  1245177   DNA mismatch repair protein                    mutS    -0.87   -0.78   1.50
  1245268   ATP-dependent RNA helicase RhlB                rhlB    -0.73   -0.83   1.07
  1245298   Excinuclease ABC subunit A                     uvrA    -0.78   ns      2.57
  1243785   Hypothetical protein PM0438                    ftsH    -0.94   -0.80   1.13
  1244083   Hypothetical protein PM0736                    DnaK    ns      -0.74   1.50
  1244087   Hypothetical protein PM0740                    dnaJ    -0.74   -0.79   1.29
  1245051   ClpB                                           clpB    -0.66   ns      2.14
  1245095   ATP-dependent protease ATP-binding subunit     hslU    -0.70   ns      2.58
  1245163   Recombination regulator RecX                   recX    -0.54   -0.78   6.44

\* Ratio of treatment/control normalized intensities. ns: no significant change in gene expression with sub-MIC of antibiotic.

![**Validation of microarray differential gene expression data by quantitative real time RT-PCR (qPCR)**. Ratio of treated vs. control were calculated for microarray data (ordinate) and qPCR data (abscissa). A total of six genes that were up or down regulated with amoxicillin, chlortetracycline or enrofloxacin were compared. The correlation coefficient r^2^ was 0.84.](1471-2164-10-S2-S4-1){#F1}

Compared to the untreated control, expression of 413, 392, and 473 genes had significantly altered expression in response to AMX, CTC, and ENR, respectively, and the overlap between treatments is shown in the Venn diagram (Figure [2](#F2){ref-type="fig"}). The extensive overlap of regulated genes with the three different antibiotics is consistent with the recent transcriptome analysis of ampicillin and ofloxacin effects in *E. coli*, which showed that these two unrelated antibiotics had a significant overlap of regulated genes \[[@B14]\].

![**Venn diagram of gene expression in response to sub-MIC antibiotics**. The data intersections between significant changes in gene expression of *P. multocida*in response to sub-MIC amoxicillin (AMX), chlortetracycline (CTC) and enrofloxacin (ENR).](1471-2164-10-S2-S4-2){#F2}

Functional analysis of DE genes: COGs
-------------------------------------

The three antibiotics used in this study have distinct modes of action; AMX is a cell wall biosynthesis inhibitor, CTC is a protein synthesis inhibitor, and ENR inhibits DNA gyrase and DNA topoisomerase IV activities \[[@B15]\]. At the COG category level, the three antibiotics had different effects on gene expression (Figure [3](#F3){ref-type="fig"}). The AMX and CTC treatments resulted in an overall decrease in gene expression in all COG categories. The overall suppression of gene expression could indicate that the antibiotics have a marked detrimental effect on the fitness of *P. multocida*at doses below MIC, or it is also possible that the overall transcriptional shutdown is a compensatory response by slowing metabolism. ENR had varying effects on gene expression in different COG categories. In particular, ENR caused a pronounced increase in expression of genes in categories I (lipid metabolism), J (translation, ribosomal structure and biogenesis), and L (DNA replication, recombination and repair). All three antibiotics had reduced expression of genes in COGs V (defense mechanisms), G (carbohydrate transport and metabolism), P (inorganic ion transport and metabolism) and Q (secondary metabolites biosynthesis, transport and catabolism).

![**Summary of significant changes in *P. multocida*gene expression grouped by COGs**. Numbers on the y-axis represent the percentage of genes in each COG category whose expression either significantly increased (black bars) or decreased (gray bars) in response to antibiotic treatment. COG category descriptions are: A, RNA processing and modification; K, Transcription; L, Replication, recombination and repair; D, Cell cycle control, mitosis and meiosis; V, Defense mechanisms; T, Signal transduction mechanisms; M, Cell wall/membrane biogenesis; N, Cell motility; W, Extracellular structures; U, Intracellular trafficking and secretion; O, Posttranslational modification, protein turnover, chaperones; C, Energy production and conversion; G, Carbohydrate transport and metabolism; E, Amino acid transport and metabolism; F, Nucleotide transport and metabolism; H, Coenzyme transport and metabolism; I, Lipid transport and metabolism P, Inorganic ion transport and metabolism; Q, Secondary metabolites biosynthesis, transport and catabolism R, General function prediction only; S, Function unknown; -, not in COGs](1471-2164-10-S2-S4-3){#F3}

Effects of antibiotics on known target genes
--------------------------------------------

We observed altered expression of some of the known targets (direct or inferred based on mechanism of action) with each antibiotic. CTC reduced the expression of genes encoding ribosomal proteins S4 and S7, which interact with tetracyclines \[[@B16]\]. One quarter-MIC of ENR resulted in a 1.5 fold increase in the expression of *gyrB*, which encodes a known ENR target, DNA gyrase B (Table [2](#T2){ref-type="table"}). We had previously reported that the expression of RecA protein increased in response to sub-MIC of ENR \[[@B10]\], and in the current study we detected increased expression of *recA*. With AMX, except for the expression of *ponC*, there were no detectable differences in the expression of genes encoding penicillin binding proteins (pbp). There was a 50% decrease in *ponC*(pbp) gene expression. However, this was a not an AMX specific effect, as all three antibiotics caused a decrease in *ponC*gene expression.

###### 

Changes in specific target gene expression in response to sub-MIC of antibiotics

  GeneID    Product Name               Locus   AMX\*   CTC\*   ENR\*   COG(s)
  --------- -------------------------- ------- ------- ------- ------- ----------
  1244738   30S ribosomal protein S4   rpsD    ns      -0.82   1.29    COG0522J
  1244702   30S ribosomal protein S7   rpS7    1.11    -0.93   1.69    COG0049J
  1244823   DNA gyrase subunit B       gyrB    ns      1.36    1.45    COG0187L
  1245164   Recombinase A              recA    ns      ns      9.96    COG0468L
  1243991   PonC                       ponC    -0.55   -0.56   -0.62   COG4953M

\*Ratio of treatment/control normalized intensities. ns: no significant change in gene expression with sub-MIC of antibiotic.

While regulation of expression of known targets is an expected response to antibiotics, it is not a consistent finding; expression of the target is usually not affected. For example, microarray analysis showed that enrofloxacin, trimethoprim, brodimoprim, and cefquinome had no effects on expression of their targets in *P. multocida*\[[@B12]\]. However, even though expression of the known antibiotic target is often not affected, bacteria typically have a \"signature\" gene expression response to specific antibiotics. Indeed, bacterial transcription profiles are now sometimes used to obtain initial indications of the mechanism of action for new compounds \[[@B17],[@B18]\].

Common trends in response to AMX, CTC and ENR
---------------------------------------------

Despite differences in their mechanism of action, the majority of genes with significantly altered expression (282) were common to all three antibiotics (Figure [2](#F2){ref-type="fig"}). Beyond the effects on specific target gene expression, antibiotics are known to cause secondary effects on genes involved in general physiology as part of the adaptive response to antibiotic stress. A hallmark of recently described antibiotic mediated bacterial cell death common to bactericidal antibiotics in *E. coli*is the generation of hydroxyl radicals with subsequent induction of SOS response \[[@B19],[@B20]\]. These effects were noted for MIC as well as sub-MIC concentrations of the antibiotics. There is increasing appreciation for the fact that fine tuning of these responses is unique to each organism and needs to be evaluated as such to facilitate identification of targets that potentiate the bactericidal activity of antibiotics. The *P. multocida*genome is known to contain genes necessary for antibiotic mediated SOS response \[[@B6]\] (for example, *sulA*, which is necessary for beta-lactam mediated SOS response).

Antibiotic stress in *P. multocida*resulted in increased ATP synthesis (Additional file [2](#S2){ref-type="supplementary-material"}, supplemental table 2). While this effect has been described for gyrase inhibitors \[[@B21]\], in *P. multocida*this response was common to all three antibiotics. In particular, all three antibiotics influenced gene expression involved in *de novo*nucleotide biosynthesis. The overall effects on expression of *purM*(increase), *purK*(decrease), and *purF*(decrease) could reduce the intracellular concentrations of IMP, while increased expression of *pyrG*and *pyrF*with ENR could result in increased concentrations of CTP and UDP.

Both AMX and CTC impaired the expression of *hsp90*, thus affecting proper protein folding under stress conditions in *P. multocida*. All three classes of antibiotics adversely affected putrescine (*potE*), ribose (*rbscA*and *rbscC*), and molybdate (*modC*) transport systems. Alterations to *modC*expression could have wide ranging effects on bacterial physiology due to effects on the synthesis of molybdoenzymes (Additional file [2](#S2){ref-type="supplementary-material"}, supplemental table 2). Reduced levels of polyamines like putrescine could have profound negative effects on protein translation and impair the ability to cope with oxidative stress \[[@B22]\].

Expression of 121 genes annotated as coding for hypothetical proteins were altered in response to the antibiotics (Additional file [1](#S1){ref-type="supplementary-material"}, supplemental table 1). Lack of functional information for these genes hampers our understanding of their role in adaptation of *P. multocida*to antibiotic stress and demonstrates the need for continuous functional annotation of genes beyond the initial annotation that is described with the genome sequence.

One of the demonstrated outcomes of antibiotic stress in *E. coli*is alterations in iron homeostasis; namely, expression of genes involved in siderophore mediated iron transport are affected (for example, *fecC*) \[[@B19]\]. In *P. multocida*, expression of genes encoding iron transporters *fecC*and *fecE*were reduced when it was grown in the presence of 1/4 MIC of AMX or ENR (Additional file [2](#S2){ref-type="supplementary-material"}, supplemental table 2).

Changes in the ratio of NAD+/NADH are known to influence the levels of toxic superoxide formation, which ultimately leads to hydroxyl radical formation. NADH I levels are directly linked to the activities of TCA cycle enzymes that generate NADH from NAD+ \[[@B19]\]. ENR treatment caused decreased expression of *sucB*, and all three antibiotics caused decreased *lpdA*expression, which could reduce hydroxyl radical formation. Expression of the gene encoding anaerobic respiration electron transfer enzyme molybdoenzyme dimethylsulfoxide reductase was reduced in response to AMX and ENR. AMX treatment reduced the expression of acetyl-CoA carboxylase enzyme (*accB, accD*), which catalyzes the first step of type II fatty acid biosynthesis as well as the step catalyzed by acyl carrier protein S-malonyltransferase (*fabD*); by contrast, ENR increased the expression of these genes, which could result in increased fatty acid biosynthesis.

DE genes: network analysis
--------------------------

COG analysis of DE genes was useful for identifying overall trends at a broad functional category level. Gene ontology (GO) analysis of *P. multocida*, which is available through Uniprot, was useful to some extent in adding specific functions to the genes within each of the broad functional categories represented by COGs. However, neither of these two approaches could actually show exactly how the genes within a functional category were interacting with each other to bring about a specific function. To enable network analysis, we used Pathway Studio to build interaction networks for all DE *P. multocida*genes with AMX, CTC and ENR. Careful analysis of these networks revealed expression cascades for some of the DE genes common to CTC and ENR.

Expression of *fnr*increased in response to sub-MIC of CTC and ENR (Figure [4](#F4){ref-type="fig"}). Fnr regulates the transcription of many genes that are involved in either aerobic or anaerobic respiration, including Nap nitrate reductase, which facilitates nitrate reduction in the periplasmic space. Expression of *napD*and *napF*increased in response to ENR and decreased with CTC (Additional file [3](#S3){ref-type="supplementary-material"}, supplemental figure 1). NapD is a chaperone protein that is specific for NapA and is required for the stability of NapA protein. NapF stimulates the Nap reductase. NapF promoters regulate the transcription of *cmABCDEFGH*operon in *E. coli*, which constitutes the cytochrome biogenesis system. Expression of *ccmH*increased with CTC and decreased with ENR (Table [3](#T3){ref-type="table"}). The identification of this cascade of gene regulation was possible by combining the network analysis with the functional information available at EcoCyc. The implications of up regulation of enzymes that facilitate anaerobic respiration in response to antibiotics remain unclear at present.

###### 

Fnr regulated genes and their response to sub-MIC of chlortetracycline and enrofloxacin

  GeneID    Product Name                                           Locus    CTC\*   ENR\*
  --------- ------------------------------------------------------ -------- ------- -------
  1244015   Fumarate/nitrate reduction transcriptional regulator   fnr      1.49    1.43
  1243352   Cytochrome c biogenesis protein CcmA                   ccmA     -0.70   1.80
  1243353   CcmB                                                   ccmB     -0.45   1.27
  1243356   cytochrome c-type biogenesis protein CcmE              ccmE     -0.77   -0.57
  1243357   CcmF                                                   ccmF     ns      -0.44
  1243359   CcmH                                                   ccmH_1   1.41    -0.43
  1243360   CcmH                                                   ccmH_2   1.56    -0.52
  1244939   Hypothetical protein PM1592                            napF     -0.50   2.11
  1244940   NapD                                                   napD     -0.52   1.35
  1244941   Nitrate reductase                                      napA     -0.81   -0.76
  1244945   NapC                                                   napC     1.40    -0.68

\* Ratio of treatment/control normalized intensities. ns: no significant change in gene expression with sub-MIC of antibiotic.

![**Fumarate/nitrate response regulator network in *P. multocida*in response to enrofloxacin visualized in Pathway Studio**. *P. multocida*sub-MIC ENR response was marked by significant changes in *fnr*response regulated genes. Red nodes are genes with increased expression and green nodes are genes with decreased expression. The rest of the interacting nodes are shown in gray. These nodes had no significant changes in expression or were orthologs from additional gram-negative species in the molecular interaction database in Pathway Studio.](1471-2164-10-S2-S4-4){#F4}

Network analysis also facilitated the identification of differences in the SOS response with different antibiotics in *P. multocida*(Figure [5](#F5){ref-type="fig"} (ENR) and Additional file [3](#S3){ref-type="supplementary-material"}, supplemental figures 2 (AMX) and 3 (CTC)). In particular, the response to ENR showed the signature gene expression pattern typical of SOS response (Figure [5](#F5){ref-type="fig"}). Increased RecA protein expression results in the cleavage of LexA repressor, thus removing the LexA mediated repression of DNA repair genes like *uvrD*. Expression of both *recA*and *lexA*genes increased in response to ENR (Table [1](#T1){ref-type="table"}). Expression of *recN*was increased, which also relieves LexA repression \[[@B23]-[@B25]\]. Genes involved in fine-tuning the actions of RecA, namely *recX*and *uvrD*, also had increased expression. Expression of primosome genes (*dnaJ*and *dnaK*) that encode enzymes required for re-starting the stalled replication fork and other replicative enzymes like DNA polymerase III increased with ENR.

![**SOS response gene network in *P. multocida*in response to enrofloxacin**. *P. multocida*sub-MIC ENR response was marked by significant changes in SOS response genes. Red nodes are genes with increased expression and green nodes are genes with decreased expression. Pink nodes represent no significant changes in gene expression while gray nodes are orthologs from gram-negative species in the molecular interaction database in Pathway Studio.](1471-2164-10-S2-S4-5){#F5}

It is reported that beta lactam mediated cell killing involves SOS response through SulA and DpiBA two component system \[[@B26]\]. Based on the genome annotation of Pm70 \[[@B6]\], all the components of this regulon are not present. There was no induction of the expression of *recA*or *lexA*with AMX (Additional file [3](#S3){ref-type="supplementary-material"}, supplemental figure 2). The expression profile of SOS response genes remained either unchanged or showed decreased expression, which indicates that sub-MIC AMX does not activate SOS response in *P*. *multocida*. Excluding the increased expression of *lexA*and *gyrB*, CTC (Additional file [3](#S3){ref-type="supplementary-material"}, supplemental figure 3) also did not activate SOS response.

DE virulence genes
------------------

Productive infection by bacterial pathogens relies on the expression of virulence factors that have wide ranging functions like competence, adherence, capsule synthesis and export, evading host immune responses etc. Transcription profiling of the response of a bovine *P. multocida*isolate (L386) to MIC of eight different antibiotics identified mostly reduced virulence gene expression \[[@B12]\]. In the current study, transcription profiling of the *P. multocida*response to AMX, CTC and ENR identified significant changes in the expression of known and putative virulence genes. AMX and CTC reduced the expression of *ompA*, a known virulence factor of *P. multocida*involved in binding to host cells \[[@B27]\] (Table [4](#T4){ref-type="table"}). AMX and CTC decreased expression of the gene encoding detoxifying enzyme superoxide dismutase, which is one of the virulence genes identified in the *P. multocida*L386 study \[[@B12]\]. Additional virulence factors (based on L386 study) which had reduced expression in Pm70 are: *clpB*protease with AMX, capsule transport protein *hexA*with all three antibiotics, PM1714 regulator with AMX and CTC, capsule biosynthesis genes *phyA and hyaE*with AMX and CTC, *phyB*with CTC, and tight adherence gene *tadB*with AMX. Expression of *dnaK*, which is required for virulence in a number of bacterial pathogens \[[@B26]\], was decreased by CTC.

###### 

Effects of sub-MIC of antibiotics on *P. multocida*putative virulence factors

  GeneID    Product Name                  Locus   AMX\*   CTC\*   ENR\*
  --------- ----------------------------- ------- ------- ------- -------
  1244083   Hypothetical protein PM0736   DnaK    ns      -0.74   1.50
  1244119   PhyB                          phyB    ns      -0.84   1.41
  1244120   PhyA                          phyA    -0.80   -0.71   1.71
  1244121   HyaE                          hyaE    -0.64   -0.91   1.27
  1244128   HexA                          hexA    -0.74   -0.69   -0.73
  1244133   Hypothetical protein PM0786   OmpA    -0.83   -0.75   ns
  1244195   Hypothetical protein PM0848   tadB    -0.51   ns      ns
  1245051   ClpB                          clpB    -0.66   ns      2.14
  1245061   Hypothetical protein PM1714   \-      -0.74   -0.91   ns

\* Ratio of treatment/control normalized intensities. ns: no significant change in gene expression with sub-MIC of antibiotic.

Conclusion
==========

Our global transcriptome analysis of *P. multocida*response to three antibiotics with differing modes of action identified gene expression changes in a little over a quarter of the annotated open reading frames in the genome. The antibiotics had varying effects on various cellular and metabolic functions. Amoxicillin reduced the overall transcription rate as reflected by the majority of the identified significant changes in gene expression showing a downward trend in expression. An interesting aspect of the AMX response was the marked lack of expression of SOS response genes. Enrofloxacin, a DNA gyrase inhibitor, resulted in the significant overexpression of its target gene and induced a typical SOS response. Analysis of DE genes in the context of interacting protein networks facilitated the identification of coordinated regulation of gene expression across different COG functional categories. Sub-MIC of antibiotics influenced the expression of virulence factors in *P. multocida*. Our results form the framework for understanding the global effects of antibiotics on *P. multocida*, which will aid rational drug design for containing as well as treating infections caused by this pathogen across multiple species.

Methods
=======

Bacterial culture and RNA isolation
-----------------------------------

*P. multocida*Pm70 was cultivated in brain heart infusion broth (BHI) at 37°C with rotary aeration. Minimum inhibitory concentrations (MICs) of AMX, CTC and ENR for Pm70 are 0.5 μg/ml, 4 μg/ml, and 0.031 μg/ml, respectively \[[@B10]\]. Growth kinetics of Pm70 in the presence of 1/4 MIC of the three antibiotics were previously described \[[@B10]\]. Stationary phase cultures of Pm70 were used to inoculate 50 ml BHI to an initial A~600~of 0.05; antibiotic treated cultures contained 1/4 MIC of AMX, CTC, or ENR, and control cultures were grown without antibiotics. For each treatment, cultures were grown in triplicate to mid-log phase (A~600~of 0.8). RNAprotect (Qiagen) was added to culture samples, and bacteria were harvested by centrifugation (10,000 × g, 10 min, 4°C). Pellets were stored at -80°C.

Total RNA from three biological replicate cultures (for untreated control culture as well as antibiotic treated cultures) was isolated using Qiagen RNeasy kit using the manufacturer\'s protocol. The quality and concentration of RNA was determined by Agilent Bioanalyzer.

Microarrays and data analysis
-----------------------------

A custom oligonucleotide microarray consisting of all the 2015 annotated open reading frames (ORFs) of *Pasteurella multocida*strain Pm70 was constructed by NimbleGen Systems. The array design included 23 perfect match (PM) and mismatch (MM) probes per target gene, and each probe was spotted twice. Reverse transcription, cDNA labeling, and hybridization were conducted by NimbleGen Sytems according to their established protocols. Briefly, three independent RNA samples (10 μg each) from untreated and antibiotic treated Pm70 were reverse transcribed using Random Hexamer (Gibco) and SuperScript II Reverse Transcriptase (Invitrogen). Biotin end-labeling of cDNA utilized Terminal Deoxynucleotidyl Transferase (Promega) with Biotin-N6-ddATP (Perkin Elmer); hybridization and washes were conducted using NimbleGen Systems protocol. Detection of hybridized biotin-labeled probe used Fluorolink Cy3 Labeled Streptavidin (Amersham Pharmacia).

Raw intensity data (single channel) were log transformed, and normalization was done by quantile normalization \[[@B28]\] and robust multichip analysis (RMA) algorithm \[[@B29]\]. The experimental design and all microarray data have been deposited in the NCBI Gene Expression Omnibus (GEO, <http://www.ncbi.nlm.nih.gov/geo/>, accession number GSE12779). ANOVA followed by step-down Bonferroni correction for multiple testing was conducted to identify genes with significant changes in expression relative to untreated control (p ≤ 0.05) in any group. Significant changes between control vs specific antibiotic treatments were identified by performing Dunnett\'s test \[[@B30]\]. The differences in gene expression in response to antibiotics were calculated as the ratio of treatment vs control intensities.

Real time RT-PCR
----------------

The majority of significant changes in gene expression identified in this study were less than one-fold. Therefore, to validate changes in gene expression, we performed duplex real time quantitative RT-PCR (qPCR) of six genes: *gyrb, impA, rpsg, hpkR, recQ*, and *murA*using *gapdh*as the internal standard. The RNA template used for qPCR was the same RNA that was used for microarray hybridizations. The probes and primers for duplex RT-PCR were designed using Beacon Designer software (Additional file [4](#S4){ref-type="supplementary-material"}, supplemental table 3). Reactions were performed using the Platinum^®^SYBR^®^Green One-Step qRT-PCR Kit (Invitrogen Corporation, Carlsbad, CA). Amplification and detection of specific products were done using the iCycler iQ Real-Time PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA). Regression analysis of the C~t~values of the test RT-PCRs was used to generate standard curves. The mean C~t~value for the GAPDH mRNA-specific reactions was used to normalize the test values. Regression analysis of the gene expression trends determined by qPCR and microarray analysis was performed in Microsoft Excel.

Functional analysis of differentially expressed genes
-----------------------------------------------------

Initial functional analysis of genes with significant changes in expression was done using clusters of orthologous groups (COG) classification \[[@B31]\]. For each COG category in the genome, the percent increase or decrease in expression of genes belonging to that category for each antibiotic treatment was calculated. The COG functional categories described for *P. multocida*genes \[[@B6]\] along with the description for proteins encoded by the genes at Uniprot \[[@B32]\] were used to identify overall themes in antibiotic response. Specific functions of *P. multocida*proteins were deduced from information available for *E. coli*orthologs at the EcoCyc database \[[@B33]\]. Network analysis of DE genes was done in Pathway Studio (Ariadne Genomics) as described earlier \[[@B11]\]. Briefly, we built interaction networks in Pathway Studio with proteins of interest including the upstream regulators and downstream targets. In the interaction networks, different colors were used for nodes to indicate significant increase (red), decrease (green), or no change (pink) in gene expression in response to sub-MIC of antibiotic. Entities in the interaction map that were not present in the Pm70 genome were shown in gray color.
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###### Additional file 1

Significant changes identified in *P. multocida*gene expression with AMX, CTC and ENR.
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###### Additional file 2

Supplemental table 2. Significant changes identified in *P. multocida*gene expression common to more than one antibiotic.
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###### Additional file 3

**Supplemental figures. Interaction networks**. The network diagrams show changes in gene expression in response to sub-MIC. Red and green indicate significant increase and decrease in expression respectively. Genes whose expression did not change (pink) and genes in the network from other bacteria (gray) are also included. *Supplemental figure 1*. fnr regulated genes with CTC administration. *Supplemental figure 2*. Interaction network with genes involved in SOS response with AMX administration. *Supplemental figure 3*. Interaction network with genes involved in SOS response with CTC administration.
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###### Additional file 4

**Supplemental table 3. Quantitative RT-PCR probes and primers**. The sequences of primers used for qPCR validations of selected gene expression changes in microarray.
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